Back to search results

SHARE-MC Educational Intervention for Sexual Health in Metastatic Breast Cancer

This study is testing an educational program called SHARE-MC for women with metastatic breast cancer (cancer that has spread to other parts of the body). The program aims to help with sexual health and overall well-being. You might be able to join if you are a woman aged 18 or older with metastatic breast cancer and are experiencing significant sexual dysfunction. The study will look at whether the SHARE-MC program improves sexual function, measured by a score called the Female Sexual Function Index (FSFI). The current status of this study is unclear, but it plans to enroll about 96 women.

Study design
This study will randomly assign participants to either a group education session (SHARE-MC) or an individual self-management session (Informational Booklet). About 96 women are expected to participate.
What's involved
You would complete questionnaires, participate in video conferences, and attend an educational session. Your participation is expected to last about 16 weeks.
Compensation
Not stated in the trial record.
Follow-up
The main measure of success will be checked up to 8 weeks after the start of the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07519200

Sexual Health and Rehabilitation for Women With Metastatic Breast Cancer (SHARE-MC): An Educational Intervention

Not Yet Recruiting
NAAges 18+InterventionalSupportive care
Dana-Farber Cancer Institute
~96 participants
Updated 2026-04-09 on ClinicalTrials.gov
What's tested:SHARE-MCInformational Booklet

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Female Sexual Function Index (FSFI) Full-scale Score Change from Baseline
Measured over Up to 8 weeks

Conditions

Metastatic Breast Cancer

Explore related trials

Breast Carcinoma

Where it's being run

1 sites across 1 states
Massachusetts1

Study leadership

  • Sharon Bober · PRINCIPAL_INVESTIGATOR · Dana-Farber Cancer Institute

Who to contact

Sharon Bober
[email protected]
6176326547
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Women diagnosed with metastatic breast cancer
Age ≥ 18
Functionally appropriate to participate in the intervention, as assessed by 3 functional assessment items from the EQ-5D (see Eligibility Screening, Appendix A)
Bothered by significant sexual dysfunction as evidenced by a Female Sexual Functioning Index (FSFI) score of ≤26. (See Eligibility Screening, Appendix A)
Ability to read and write in English
Regular access to the internet

Exclusion

Diagnosis of any cancer prior to age 18
Has never been sexually active
Prior participation in Dr. Bober's sexual health research studies or workshops; or previous appointments with Dr. Bober through the DFCI Sexual Health Program.
Any impairment (e.g., hearing, visual, cognitive) that interferes with the ability to complete all study procedures independently

What this trial measures

  • Female Sexual Function Index (FSFI) Full-scale Score Change from BaselineUp to 8 weeks

    The FSFI is a well-validated 19-item instrument assessing sexual function including lubrication, orgasm, pain and satisfaction. The total sexual function score is the sum of all domain scores, ranging from 2.0 (indicating not sexually active and no desire) to 36.0. A domain score of 0.0 means there was no sexual activity during the past month. Higher scores, both for individual domains and the total score, reflect better sexual functioning.